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[~Two adult patients with Cystic Fibrosis, both lung transplanted, 
developed acute intestinal intussusseption which revealed a 
lymphoma 
A. Bel Hadj Hassine 1, I. Danner-Boucher 1 , D. Horeau-Langlard 1 , V Roland 2, 
M.E Heyman 3, R Despins 1. 1Lung and Heart transplantation Unit, 2Hematology 
unit. H@ital Hdtel-Dieu, 3Anatomopathology unit. H@ital GR LaYnnec, Nantes', 
France 
Gastrointestinal disorders are frequent in cystic fibrosis. Occurrence of acute 
intestinal intussusseption is common with children, in fact it is idiopathic in 90 
to 95% of the cases and it does not need a surgical treatment. It is however very 
rare in adults. 
We are reporting the clinical case of two adults both lung transplanted who were hos- 
pitalized for persistent subocclusive syndrome in spite of a symptomatic treatment. 
Then we discovered typical acute intestinal intussusseption the ultrasonography 
and confirmed by the CT Scan. We decided on a surgical exploratory operation and 
found intestinal intussusseption was caused by a tumor located on the small bowel 
in the two cases. The anatomopathologic study showed a lymphoma type B with 
large cells. EBV replication was found in the blood of the two patients at the time 
of the diagnosis. The first patient, 32 years old, lung and heart transplanted for 
6 months with a missmatch EBV, had a positive marking CD20 of the tumor. She 
received antiCD20 antibodies. The second patient, 28 years old, lung transplantated 
for 9 years, had an EBV positive serology before her transplantation. The tumor 
did not show the CD20 markings. The patient has since been on an on going 
chemotherapy treatment by CHOR 
Conclusion: The need for surgical exploration for subocclusive syndrome is rather 
rare in cystic fibrosis but the discovery of an intestinal intussusseption in the adult 
must entail surgical exploration because of the higher risk of neoplasy especially 
in transplanted patients exposed to lymphoma. 
6. Gastroenterology 
~ Hepatobiliary disease in Cystic Fibrosis patients 
I.M. Popa 1 , I. Popa 1 , L. Pop 1 , Z. Popa 2, S. Turcu 1 . 1pediatric II Department, 
University of Medicine and Pharmacy "Victor Babe}"; 2 CF Centre, Timi}'oara, 
Romania 
Aim study: to evaluate the frequency of hepatobiliary CF associated isease and 
possible relations with recognized risk factors, like male gender, age at diagnosis, 
history of meconium ileus and severe genotype. 
Materials and methods: study lot included 85 children (male 29, female 56), 
median age at diagnosis 10.5yrs, ranging from 1 month to 18yr. Patients 
were followed up by clinical assessment, liver function tests (LFTs), abdominal 
ultrasound examinations (US); in some cases hepatobiliary scintigraphy, liver biopsy 
was performed. We defined liver disease (LD) by the presence of at least 2 findings: 
hepato-or/and splenomegaly, elevation of LFTs or US changes in liver texture. 
Results: Hepatobiliary disease was diagnosed in 36 patients (42, 35%), boys 
predominating (66.6%). The most frequent expression was LD: 23 patients. Hep- 
atosteatosis occurred in about 60°/0 and microgallbladder in 8.23°/0 patients. Among 
patients younger than 10 years (n 56) 11.76°/0 were diagnosed with hepatobiliary 
disease. In patients older than 10, 30.59°/0 had hepatobiliary disease; 20°/0 with LD. 
Six patients (7%) developed multilobular cirrhosis(4 biopsied) associating severe 
genotype and pancreatic nsufficiency. Two children, although AF508 homozygous, 
were pancreatic sufficient. History of meconium ileus was present in 15 children 
(65.2% from all patients with LD). 
Conclusions: The frequency of hepatobiliary CF associated disease is rising. Male 
children older then 10 yr, with severe genotype and history of meconium ileus are 
more likely predisposed to develop liver disease. 
[•  Different evolution in CF patients with hepatobiliary disease and 
identical genotype 
I.M. Popa 1 , I. Popa 1 , L. Pop 1 , Z. Popa 2, S. Turcu 1 , L. T~ma~ 3. 1Pediatric II 
Department, University of Medicine and Pharmacy "Victor Babe~' '; 2 CF Centre, 
3Biochemistry Department, University of Medicine and Pharmacy "Victor Babe}' ';
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Introduction: Hepatobiliary CF-associated disease has various clinical expressions. 
Liver disease is correlated with male gender, severe genotype and history of 
meconium ileus and seems to be frequent in patient AF508 homozygous. 
Aim study: to evaluate the clinical course of CF-associated hepatobiliary disease 
in children with similar genotype. 
Materials and methods: We evaluated the phenotype and clinical course in three 
children with cystic fibrosis associating hepatobiliary disease and similar genotype: 
AF508 homozygous. The diagnosis plan included: clinical examination, biochemical 
tests, abdominal ultrasounds + Doppler, hepatobiliary scintigraphy and liver biopsy. 
Results: First case: 8-yr-old girl has severe liver disease, with portal hypertension 
and multilobular cirrhosis but without pancreatic insufficiency (no enzyme supple- 
ment need) and moderate failure to thrive. Pulmonary status is excellent. 
Second case: same age, diagnosed at birth with meconium ileus, the disease is 
manifest only with microgallbladder; pancreatic insufficiency associated. He has 
great nutritional status and well respiratory condition. 
The third case: 9-yr-old boy presents multilobular cirrhosis with portal hypertension 
and portal encephalopathy, related diabetes with poor glycemic ontrol, needing a 
small dose of pancreatic enzyme supplement. 
Conclusions: There is no current explanation why liver disease develops in some 
patients and not in others. Different evolution of cases with same genotype remains 
unexplained, suggesting the possible role of "genetic modifiers" influencing disease 
expression. 
OLiver  disease in Cystic Fibrosis - prevalence and predisposing 
factors 
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Aims: To establish the prevalence of clinically significant CF related liver disease 
(CFRLD), defined as clinical or imaging evidence of multilobular cirrhosis and/or 
portal hypertension. To identify predisposing factors for CFRLD. 
Methods: Retrospective analysis of all CF patients (>1 yr) followed in Toronto. 
The Toronto Database was used to screen for liver disease. Chart review was used 
to verify disease status and validate database search strategies. 
Results: 1108 CF patients attended the CF clinics from 1986 to 2004. Database 
search strategies identified 17 patients as CFRLD, 157 as QUERY CFRLD and 
934 as NO CFRLD. Chart reviews confirmed CFRLD in all 17 screen positive 
patients and 32 of 157 QUERY patients. An additional 3 patients with CFRLD 
were identified from prior liver studies. A random sample of 111 patients from the 
NO CFLRD group did not reveal further CFRLD. Prevalence of CFRLD increased 
over the study period; 1986 89 1.7%, 1990 94 3.1%, 1995 99 4.7%, 2000 04 
6.0%. Pancreatic insufficiency (PI) was significantly associated with CFRLD (OR 
3.3, 95% CI 1.03 to 10.85, p 0.03). Gender (65% males in CFRLD, 55% in 
NO CFRLD, p 0.17) and meconium ileus (17% in CFRLD, 15% in NO CFRLD, 
p 0.76) were not significantly associated. 
Conclusions: A database search strategy was useful to screen for CFRLD. Preva- 
lence of CFRLD in Toronto was lower than in most previous reports. Increasing 
prevalence over time is possibly due to increased awareness of subtle clinical 
manifestations of CFRLD and improved survival. CFRLD was associated with PI, 
but unlike previous tudies there was no evidence of an association with meconium 
ileus or gender. 
